Shanghai Allist Pharmaceuticals Co Ltd
Shanghai Allist Pharmaceuticals Co., Ltd., a pharmaceutical company, engages in the research and development of tumor-targeted drugs in China in internationally. The company's lead product is vometinib mesylate tablet for the treatment of patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer (NSCLC). It also develops pralatinib capsules, as well as glerexyl citrate tablets for treating adult patients with locally advanced or metastatic NSCLC. The company was founded in 2004 and is based in Shanghai, China.
If you'd bought from year…
Same habit, different start year. Each row shows what a constant habit's worth of 688578-SS would be worth today, had you started buying at that point in the asset's history.
| Started | $6/day$6/day coffee | $42/wk$42/week coffee |
|---|---|---|
| Year 1 (2020) — listing | $20,493 2.6× | $30,195 2.6× |
| Year 6 (2025) | $2,002 1.0× | $3,000 1.0× |
Repeated investment, no fees, dividends reinvested. $6/day coffee = $180 / month equivalent.
Popular scenarios with 688578
For illustration only — not investment advice. Past performance is not indicative of future results.